Rob Hopfner - Profile and Investment Details

Investor Profile

Rob Hopfner is a Venture Capital, Private Equity Firm, Investor based in San Francisco, California, United States with a diverse investment portfolio that includes companies such as Civitas Therapeutics, Hyperion Therapeutics, Oculis, Inozyme, Bay City Capital LLC, Vtesse, Inc., Dermira, Inc., Vaxcyte, Inozyme Pharma, PTC Therapeutics, Inc., Rallybio, Evommune, LAND Therapeutics, Plexium, NextWave Therapeutics, Aciex Therapeutics, Inc., . Over time, Rob Hopfner has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Rob Hopfner is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Drug Discovery, Data Science, Wellness, Healthcare Innovation, Life Science, Portfolio Management, Medical Technologies, Finance, Biotechnology, Innovation, B2B, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with Rob Hopfner, as their portfolio suggests a familiarity and interest in this area.

Understanding Rob Hopfner’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.